retatrutide weight loss clinical UK 2026: Phase 3 Results VisualAbstract: Retatrutide reduces body weight
Description
Adequate protein intake supports satiety hormones, including GLP-1
Yes, in many cases
The company disputes these allegations, and each case is assessed individually based on evidence, not assumptions
Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke or death in those who are also at high risk for these events
Furthermore, another secondary analysis of the STEP-HFpEF and STEP-HFpEF DM trials showed that semaglutide reduced C-reactive protein levels and improved symptoms, physical limitations, and exercise function in HFpEF obese patients [84]
